Literature DB >> 16788787

[MR techniques for noninvasive diagnosis of prostate cancer].

N Morakkabati-Spitz1, P J Bastian, A Meissner, F Träber, J Gieseke, H H Schild, S C Müller.   

Abstract

The diagnosis of prostate cancer is suggested on the basis of an elevated PSA level, abnormal digital exam, and abnormal transrectal ultrasound. US-guided biopsy is used to confirm the diagnosis, but up to 30% of prostate cancer may be missed with this approach. Meanwhile MR imaging and proton MR spectroscopy have emerged as the most sensitive additional tools for the noninvasive evaluation of prostate cancer. This article reviews the clinical indications for MRI of the prostate and summarizes new techniques such as high field strength (3 tesla) and dynamic contrast-enhanced MRI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788787     DOI: 10.1007/s00120-006-1063-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

1.  Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging.

Authors:  Fergus V Coakley; Steven Eberhardt; David C Wei; Evan S Wasserman; Stefan B J Heinze; Peter T Scardino; Hedvig Hricak
Journal:  Urology       Date:  2002-06       Impact factor: 2.649

2.  3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).

Authors:  B Nicolas Bloch; Neil M Rofsky; Ronaldo H Baroni; Robert P Marquis; Ivan Pedrosa; Robert E Lenkinski
Journal:  Acad Radiol       Date:  2004-08       Impact factor: 3.173

3.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.

Authors:  Jacob Sosna; Ivan Pedrosa; William C Dewolf; Houman Mahallati; Robert E Lenkinski; Neil M Rofsky
Journal:  Acad Radiol       Date:  2004-08       Impact factor: 3.173

4.  Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING).

Authors:  J Star-Lack; S J Nelson; J Kurhanewicz; L R Huang; D B Vigneron
Journal:  Magn Reson Med       Date:  1997-08       Impact factor: 4.668

5.  Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

Authors:  Jeong Kon Kim; Seong Sook Hong; Young Jun Choi; Seong Ho Park; Hanjong Ahn; Choung-Soo Kim; Kyoung-Sik Cho
Journal:  J Magn Reson Imaging       Date:  2005-11       Impact factor: 4.813

6.  Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.

Authors:  Emanuele Casciani; Elisabetta Polettini; Luca Bertini; Paolo Emiliozzi; Mostafa Amini; Vito Pansadoro; Gian Franco Gualdi
Journal:  Radiol Med       Date:  2004 Nov-Dec       Impact factor: 3.469

7.  Prostate cancer staging: should MR imaging be used?--A decision analytic approach.

Authors:  G J Jager; J L Severens; J R Thornbury; J J de La Rosette; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

Review 8.  Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.

Authors:  Filip G Claus; Hedvig Hricak; Robert R Hattery
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

9.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.

Authors:  J Kurhanewicz; D B Vigneron; H Hricak; P Narayan; P Carroll; S J Nelson
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

10.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.

Authors:  Michael Mullerad; Hedvig Hricak; Liang Wang; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

View more
  2 in total

1.  [Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Authors:  I Damjanoski; J Müller; T J Schnöller; R Küfer; L Rinnab
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

Review 2.  [Nuclear imaging of prostate cancer: current status].

Authors:  S N Reske
Journal:  Urologe A       Date:  2007-11       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.